Financial results for Q3 ended September 30, 2024
GlaxoSmithKline (Pakistan) Limited (GLAXO) · View GLAXO share price and financials
Published
Announcement summary
This page records a Pakistan Stock Exchange corporate announcement from GlaxoSmithKline (Pakistan) Limited. Review the original filing for the complete terms and regulatory disclosure.
- Unconsolidated Sales
- 14730940
- Unconsolidated Pat
- 1927134
- Unconsolidated Quarter Eps
- 6.05
- Unconsolidated Cumulative Eps
- 11.25